SurgePays
SURG
#10028
Rank
NZ$54.1 M
Marketcap
NZ$2.57
Share price
-12.35%
Change (1 day)
-17.11%
Change (1 year)

Revenue for SurgePays (SURG)

Revenue in 2025 (TTM): NZ$86.8 Million

According to SurgePays's latest financial reports the company's current revenue (TTM ) is NZ$86.93 Million. In 2024 the company made a revenue of NZ$0.10 Billion a decrease over the revenue in the year 2023 that were of NZ$0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SurgePays from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$86.8 M-19.59%
2024 NZ$0.10 B-50.22%
2023 NZ$0.21 B13.28%
2022 NZ$0.19 B156.09%
2021 NZ$74.75 M-0.86%
2020 NZ$75.4 M97.27%
2019 NZ$38.22 M68.19%
2018 NZ$22.72 M1028.79%
2017 NZ$2.01 M-57.7%
2016 NZ$4.75 M
2014 NZ$0 M23%
2013 NZ$0 M10.14%
2012 NZ$0 M-29.19%
2011 NZ$0 M-83.96%
2010 NZ$0.01 M19.28%
2009 NZ$0.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
STAAR Surgical
STAA
NZ$0.39 B 357.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
NZ$2.83 B 3,161.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cooper Companies
COO
NZ$6.98 B 7,931.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$42.07 B 48,301.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$159.03 B 182,834.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$97.28 B 111,810.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
CONMED
CNMD
NZ$2.32 B 2,575.01%๐Ÿ‡บ๐Ÿ‡ธ USA